Ainos and SIDSCO will cooperate to accelerate the development of new animal drugs based on Ainos' VELDONA® low-dose oral interferonUpcoming…
VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7), a diagnostics technology company, is pleased to…
HighlightsAHI signs binding term sheet with OneClinic, an electronic medical record (EMR) and personal health record (PHR) supplier for Vietnam.OneClinic…
BOULDER, CO / ACCESSWIRE / November 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…
Potential to address cancer treatment related Cytokine Release SyndromeLONDON, UK / ACCESSWIRE / November 3, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF),…
Revenue of $2.24 billion, up 9% on both a Reported and Organic1 basisYear-over-year revenue growth in all segments on both…
Third quarter 2023 revenues of $1.8 billion; Company expects 2023 revenues of at least $6 billionSpikevax U.S. market share to…
Analysis of week 36 data from Phase 2b ORIGIN study shows atacicept 150 mg substantially reduces serum Gd-IgA1 and resolves…
Flu season officially started October 1JEFFERSON CITY, Mo., Oct. 13, 2023 (GLOBE NEWSWIRE) -- The Missouri Department of Health and…
ORi to Be Launched in the U.S. at ANESTHESIOLOGY 2023 This WeekendSAN FRANCISCO--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that ORi™,…